BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33292789)

  • 21. Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis.
    de Jong VMT; Rousset RZ; Antonio-Villa NE; Buenen AG; Van Calster B; Bello-Chavolla OY; Brunskill NJ; Curcin V; Damen JAA; Fermín-Martínez CA; Fernández-Chirino L; Ferrari D; Free RC; Gupta RK; Haldar P; Hedberg P; Korang SK; Kurstjens S; Kusters R; Major RW; Maxwell L; Nair R; Naucler P; Nguyen TL; Noursadeghi M; Rosa R; Soares F; Takada T; van Royen FS; van Smeden M; Wynants L; Modrák M; ; Asselbergs FW; Linschoten M; ; Moons KGM; Debray TPA
    BMJ; 2022 Jul; 378():e069881. PubMed ID: 35820692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traditional Chinese medicine could increase the survival of people living with HIV in rural central China: a retrospective cohort study, 2004-2012.
    Jin Y; Guo H; Wang X; Chen X; Jiang Z; Hu G; Hou J; Jiang S; Yang X; Liu Y; Xu L; Wang N
    Am J Chin Med; 2014; 42(6):1333-44. PubMed ID: 25482679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of IMPACT, CRASH and Nijmegen models in predicting six month outcome of patients with severe or moderate TBI: an external validation study.
    Majdan M; Lingsma HF; Nieboer D; Mauritz W; Rusnak M; Steyerberg EW
    Scand J Trauma Resusc Emerg Med; 2014 Nov; 22():68. PubMed ID: 25406964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients.
    Bisaso KR; Karungi SA; Kiragga A; Mukonzo JK; Castelnuovo B
    BMC Med Inform Decis Mak; 2018 Sep; 18(1):77. PubMed ID: 30180893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current status of national free antiretroviral therapy in interprovincial migrating people living with HIV/AIDS and influencing factors, China, 2011-2015].
    Gan XM; Ma Y; Dou ZH; Zhao DC; Wu YS; Zhao Y; Yu L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Sep; 39(9):1234-1238. PubMed ID: 30293316
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.
    Feinstein MJ; Nance RM; Drozd DR; Ning H; Delaney JA; Heckbert SR; Budoff MJ; Mathews WC; Kitahata MM; Saag MS; Eron JJ; Moore RD; Achenbach CJ; Lloyd-Jones DM; Crane HM
    JAMA Cardiol; 2017 Feb; 2(2):155-162. PubMed ID: 28002550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Prognostic Model to Assess Long-Term Survival of Patients on Antiretroviral Therapy: A 15-Year Retrospective Cohort Study in Southwestern China.
    Jiang H; Zhu Q; Feng Y; Huang J; Yuan Z; Zhou X; Lan G; Liang H; Shao Y
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab309. PubMed ID: 34327255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
    [No Abstract]   [Full Text] [Related]  

  • 30. An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study.
    Friis-Møller N; Ryom L; Smith C; Weber R; Reiss P; Dabis F; De Wit S; Monforte AD; Kirk O; Fontas E; Sabin C; Phillips A; Lundgren J; Law M;
    Eur J Prev Cardiol; 2016 Jan; 23(2):214-23. PubMed ID: 25882821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.
    Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS
    AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment.
    Pilotto S; Sperduti I; Leuzzi G; Chiappetta M; Mucilli F; Ratto GB; Lococo F; Filosso PL; Spaggiari L; Novello S; Milella M; Santo A; Scarpa A; Infante M; Tortora G; Facciolo F; Bria E
    J Thorac Oncol; 2018 Apr; 13(4):568-575. PubMed ID: 29269009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
    van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
    J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and external validation of stroke prediction models demonstrates poor performance in dialysis patients.
    de Jong Y; Ramspek CL; van der Endt VHW; Rookmaaker MB; Blankestijn PJ; Vernooij RWM; Verhaar MC; Bos WJW; Dekker FW; Ocak G; van Diepen M
    J Clin Epidemiol; 2020 Jul; 123():69-79. PubMed ID: 32240769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of HIV Infection and Antiretroviral Therapy With Sudden Cardiac Death.
    Yen YF; Lai YJ; Chen YY; Lai HH; Chuang PH; Chen CC; Deng CY
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):468-474. PubMed ID: 31714425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, Ethiopia.
    Ayele W; Mulugeta A; Desta A; Rabito FA
    BMC Public Health; 2015 Aug; 15():826. PubMed ID: 26310943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination.
    Venema E; Wessler BS; Paulus JK; Salah R; Raman G; Leung LY; Koethe BC; Nelson J; Park JG; van Klaveren D; Steyerberg EW; Kent DM
    J Clin Epidemiol; 2021 Oct; 138():32-39. PubMed ID: 34175377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting 1-Year Mortality in Older Hospitalized Patients: External Validation of the HOMR Model.
    Curtin D; Dahly DL; van Smeden M; O'Donnell DP; Doyle D; Gallagher P; O'Mahony D
    J Am Geriatr Soc; 2019 Jul; 67(7):1478-1483. PubMed ID: 31050808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.